H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC

Oncotarget

Volumn 5, Issue 14, 2014, Pages 5736-5749

  Carotenuto, Marianeve ^a,b   De Antonellis, Pasqualino ^a,b   Liguori, Lucia ^a,b   Benvenuto, Giovanna ^c   Magliulo, Daniela ^a,b   Alonzi, Alessandro ^a,b   Turino, Cecilia ^d   Attanasio, Carmela ^a,b   Damiani, Valentina ^a,b   Bello, Anna Maria ^a,b   Vitiello, Fabiana ^e   Pasquinelli, Rosa ^f   Terracciano, Luigi ^g   Federico, Antonella ^h   Fusco, Alfredo ^h   Freeman, Jamie ⁱ   Dale, Trevor C ⁱ   Decraene, Charles ^j,k   Chiappetta, Gennaro ^f   Piantedosi, Francovito ^e   Calabrese, Cecilia ^d   Zollo, Massimo ^a,b,l   more..

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c STAZIONE ZOOLOGICA ANTON DOHRN   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e Dipartimento di Pneumologia e Tisiologia Day Hospital Pneumologia e Pneumoncologico AORN Vincenzo Monaldi   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g UNIVERSITY OF BASEL   (Switzerland)

^h CNR   (Italy)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

^j INSTITUT CURIE   (France)

^k CNRS   (France)

^l FEDERICO II UNIVERSITY HOSPITAL   (Italy)

more..

Author keywords

Diagnostic marker; Gsk 3 ; h Prune; Lung cancer; WNT catenin signalling; Wnt3a

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3; H PRUNE; PHOSPHATASE; TUMOR MARKER; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN; CARRIER PROTEIN; CTNNB1 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3 BETA; PRUNE PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SURVIVAL; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; ENZYME SILENCING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUNG CARCINOGENESIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; TUMOR XENOGRAFT; WNT BETA CATENIN SIGNALING; WNT SIGNALING PATHWAY; ANIMAL; BLOOD; DISEASE COURSE; ENZYMOLOGY; GENETICS; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; NUDE MOUSE; PATHOLOGY; XENOGRAFT;

ANIMALS; BETA CATENIN; CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; DISEASE PROGRESSION; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; WNT SIGNALING PATHWAY;

EID: 84906233919     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2169     Document Type: Article

References (31)

1. D'Angelo A, Garzia L, Andre A, Carotenuto P, Aglio V, Guardiola O, Arrigoni G, Cossu A, Palmieri G, Aravind L and Zollo M. Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer cell. 2004; 5(2):137-149.
2. Kobayashi T, Hino S, Oue N, Asahara T, Zollo M, Yasui W and Kikuchi A. Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions. Molecular and cellular biology. 2006; 26(3):898-911.
3. Diana D, Smaldone G, De Antonellis P, Pirone L, Carotenuto M, Alonzi A, Di Gaetano S, Zollo M, Pedone EM and Fattorusso R. Mapping functional interaction sites of human prune C-terminal domain by NMR spectroscopy in human cell lysates. Chemistry. 2013; 19(37):12217-12220.
4. Oue N, Yoshida K, Noguchi T, Sentani K, Kikuchi A and Yasui W. Increased expression of h-prune is associated with tumor progression and poor survival in gastric cancer. Cancer science. 2007; 98(8):1198-1205.
5. Zollo M, Andre A, Cossu A, Sini MC, D'Angelo A, Marino N, Budroni M, Tanda F, Arrigoni G and Palmieri G. Overexpression of h-prune in breast cancer is correlated with advanced disease status. Clin Cancer Res. 2005; 11(1):199-205.
6. Clevers H and Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012; 149(6):1192-1205.
7. Stewart DJ. Wnt signaling pathway in non-small cell lung cancer. Journal of the National Cancer Institute. 2014; 106(1):djt356.
8. Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, Mohammed S, Heck AJ, Maurice MM, Mahmoudi T and Clevers H. Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell. 2012; 149(6):1245-1256.
9. Yost C, Torres M, Miller JR, Huang E, Kimelman D and Moon RT. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes & development. 1996; 10(12):1443-1454.
10. Taelman VF, Dobrowolski R, Plouhinec JL, Fuentealba LC, Vorwald PP, Gumper I, Sabatini DD and De Robertis EM. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell. 2010; 143(7):1136-1148.
11. Barker N and Clevers H. Mining the Wnt pathway for cancer therapeutics. Nature reviews Drug discovery. 2006; 5(12):997-1014.
12. Kobayashi A, Stewart CA, Wang Y, Fujioka K, Thomas NC, Jamin SP and Behringer RR. beta-Catenin is essential for Mullerian duct regression during male sexual differentiation. Development. 2011; 138(10):1967-1975.
13. Gross JC, Chaudhary V, Bartscherer K and Boutros M. Active Wnt proteins are secreted on exosomes. Nature cell biology. 2012; 14(10):1036-1045.
14. Deb A, Davis BH, Guo J, Ni A, Huang J, Zhang Z, Mu H and Dzau VJ. SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional autofeedback loop of Wnt3a. Stem cells. 2008; 26(1):35-44.
15. MacDonald BT, Tamai K and He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Developmental cell. 2009; 17(1):9-26.
16. Lu W, Lin C, Roberts MJ, Waud WR, Piazza GA and Li Y. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/beta-catenin pathway. PloS one. 2011; 6(12):e29290.
17. Vinyoles M, Del Valle-Perez B, Curto J, Vinas-Castells R, Alba-Castellon L, Garcia de Herreros A and Dunach M. Multivesicular GSK3 Sequestration upon Wnt Signaling Is Controlled by p120-Catenin/Cadherin Interaction with LRP5/6. Molecular cell. 2014; 53(3):444-457.
18. Liu C, Kato Y, Zhang Z, Do VM, Yankner BA and He X. beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proceedings of the National Academy of Sciences of the United States of America. 1999; 96(11):6273-6278.
19. Gemma A, Li C, Sugiyama Y, Matsuda K, Seike Y, Kosaihira S, Minegishi Y, Noro R, Nara M, Seike M, Yoshimura A, Shionoya A, Kawakami A, Ogawa N, Uesaka H and Kudoh S. Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database. BMC cancer. 2006; 6:174.
20. Kuner R, Muley T, Meister M, Ruschhaupt M, Buness A, Xu EC, Schnabel P, Warth A, Poustka A, Sultmann H and Hoffmann H. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung cancer. 2009; 63(1):32-38.
21. Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, Murphy SE, Yang P, Pesatori AC, Consonni D, Bertazzi PA, Wacholder S, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PloS one. 2008; 3(2):e1651.
22. Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, Pintilie M, Der S, Seymour L, Jurisica I, Shepherd FA and Tsao MS. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol. 2010; 28(29):4417-4424.
23. Noguchi T, Oue N, Wada S, Sentani K, Sakamoto N, Kikuchi A and Yasui W. h-Prune is an independent prognostic marker for survival in esophageal squamous cell carcinoma. Annals of surgical oncology. 2009; 16(5):1390-1396.
24. Chen CY, Jan YH, Juan YH, Yang CJ, Huang MS, Yu CJ, Yang PC, Hsiao M, Hsu TL and Wong CH. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(2):630-635.
25. Kim J, You L, Xu Z, Kuchenbecker K, Raz D, He B and Jablons D. Wnt inhibitory factor inhibits lung cancer cell growth. The Journal of thoracic and cardiovascular surgery. 2007; 133(3):733-737.
26. Li D, Beisswenger C, Herr C, Hellberg J, Han G, Zakharkina T, Voss M, Wiewrodt R, Bohle RM, Menger MD, Schmid RM, Stockel D, Lenhof HP and Bals R. Myeloid cell RelA/p65 promotes lung cancer proliferation through Wnt/beta-catenin signaling in murine and human tumor cells. Oncogene. 2013.
27. Uematsu K, He B, You L, Xu Z, McCormick F and Jablons DM. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene. 2003; 22(46):7218-7221.
28. Wright PE and Dyson HJ. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. Journal of molecular biology. 1999; 293(2):321-331.
29. Bach PB, Silvestri GA, Hanger M and Jett JR. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(3 Suppl):69S-77S.
30. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E and Detterbeck F. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007; 132(3 Suppl):178S-201S.
31. Virgilio A, Spano D, Esposito V, Di Dato V, Citarella G, Marino N, Maffia V, De Martino D, De Antonellis P, Galeone A and Zollo M. Novel pyrimidopyrimidine derivatives for inhibition of cellular proliferation and motility induced by h-prune in breast cancer. European journal of medicinal chemistry. 2012; 57:41-50.